Thomas Pabst - Concepedia

Author

Thomas Pabst

Also Known As

C Renner, G. Huls, Guido Ghilardi, Pabst Thomas, Pabst, T., Pabst, Thomas, Ron Ram, T Pabst, T. Pabst, Thomas Muller Pabst

367

Publications

10.4K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Bern University of Bern University Hospital of Zurich University Hospital of Basel Erasmus MC

About

Thomas Pabst is an author at University Hospital of Bern specializing in medicine, oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	39	2.4K
2	Health Sciences	17	21	1.8K
3	Blood Transplantation	2	2	60
4	Public Health	1	1	52
5	Allergy	1	1	43

Thomas Pabst

121

Publications

Citations

H-Index

Page 1

	Year	Citations
High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia Bob Löwenberg, Gert J. Ossenkoppele, Wim van Putten, New England Journal of Medicine	2009	818
Molecular Minimal Residual Disease in Acute Myeloid Leukemia Mojca Jongen‐Lavrencic, Tim Grob, Diana Hanekamp, New England Journal of Medicine	2018	756
High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study Monique Terwijn, Wim L.J. van Putten, Angèle Kelder, Journal of Clinical Oncology	2013	444
Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial Hans Theodor Eich, Volker Diehl, Helen Görgen, Journal of Clinical Oncology	2010	431
Cytarabine Dose for Acute Myeloid Leukemia Bob Löwenberg, Thomas Pabst, Edo Vellenga, New England Journal of Medicine	2011	405
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group Peter Borchmann, Helen Goergen, Carsten Kobe, The Lancet Positron Emission TomographyAdvanced-stage HodgkinLymphoid NeoplasiaSurgical OncologyOncologic Imaging	2017	372
Molecular characterization of mutant <i>TP53</i> acute myeloid leukemia and high-risk myelodysplastic syndrome Tim Grob, Adil S. A. Al Hinai, Mathijs A. Sanders, Blood Mixed-phenotype Acute LeukemiaPathologyTumor BiologyMyeloid NeoplasiaHematological Malignancy	2022	272
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group Diana Averbuch, Gloria Tridello, Jennifer Hoek, Clinical Infectious Diseases	2017	254
Modeling of C/EBPα Mutant Acute Myeloid Leukemia Reveals a Common Expression Signature of Committed Myeloid Leukemia-Initiating Cells Peggy Kirstetter, Mikkel Bruhn Schuster, Susan Moore, Cancer Cell Hematological MalignancyCommon Expression SignatureSystems BiologyMedicineCell Biology	2008	249
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression Beatrice U. Mueller, Thomas Pabst, José Fos, Blood	2005	210

Page 1